Key result
PCSK9 AG genotype is linked to significantly higher LDL cholesterol vs AA in Nepalese subjects.
Why the study?
Is PCSK9 gene polymorphism associated with hypercholesterolemia and elevated LDL cholesterol in Nepalese subjects?
Case-Control (n=100)
Is PCSK9 gene polymorphism associated with hypercholesterolemia and elevated LDL cholesterol in Nepalese subjects?
Answers are grounded in this paper and cite their sources.
The AG genotype of the PCSK9 gene is associated with increased LDL cholesterol in a Nepalese population.
A potential gene called Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) has a gain of function mutation that causes autosomal dominant hypercholesterolemia. Diagnosing and treating genetic causes of a high cholesterol level can be challenging. Cardiovascular disorders are significantly associated with hypercholesterolemia. The study is aimed to determine the PCSK9 gene polymorphism in hypercholesterolemic Nepalese based on EarI cut site. Fifty hypercholesterolemic and fifty eucholesterolemic patients were selected for this hospital-based case-control research. Measurements were made of the biochemical parameters, anthropometry, and the comprehensive clinical history. To determine the number of potential genotypes in the Nepalese population, Polymerase Chain Reaction (PCR) and Restriction Fragment Length Polymorphism (RFLP) were performed. In the case and control groups, the AA genotype frequencies were 0.28 and 0.36, respectively. The case group's and the control group's respective AG genotype frequencies were 0.72 and 0.64. There were no wild-type GG genotypes in the case and control populations. Patients with the AG genotype had considerably higher LDL cholesterol than those with the AA genotype which was statistically significant (p = 0.03). There was a greater proportion of heterozygous AG genotype in the case group compared to the control groups, whereas homozygous AA genotype was nearly equal in both case and control groups. Two types of genotypes respectively AA and AG were identified by PCSK9/EarI genotyping in both case and control participants. In hypercholesterolemic population, the AG genotype was found to be increase in LDL cholesterol. No will type GG genotype was found in both case and control groups.
No takes yet. Share an insight, caveat, or question.
Marasini et al. (2025) conducted a case-control in Hypercholesterolemia (n=100). PCSK9 gene polymorphism (AG genotype) vs. AA genotype was evaluated on LDL cholesterol levels (p=0.03). The PCSK9 heterozygous AG genotype was associated with higher LDL cholesterol compared to the homozygous AA genotype in Nepalese subjects.
Synapse has enriched 10 related papers. Consider them for comparative context: